Cargando…

COVID-19 and the cardiovascular system: an update

As COVID-19 continues to cause an increasing number of deaths worldwide, it is important that providers stay abreast with new research related to the pathophysiology of COVID-19 disease presentation states and clinical management. It is now well recognized that COVID-19 affects extrapulmonary organs...

Descripción completa

Detalles Bibliográficos
Autores principales: Salabei, Joshua K., Asnake, Zekarias T., Ismail, Zeeshan H., Charles, Kipson, Stanger, Gregory-Thomas, Abdullahi, Abdullahi H., Abraham, Andrew T., Okonoboh, Peters
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Southern Society for Clinical Investigation. Published by Elsevier Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8830924/
https://www.ncbi.nlm.nih.gov/pubmed/35151635
http://dx.doi.org/10.1016/j.amjms.2022.01.022
_version_ 1784648385857323008
author Salabei, Joshua K.
Asnake, Zekarias T.
Ismail, Zeeshan H.
Charles, Kipson
Stanger, Gregory-Thomas
Abdullahi, Abdullahi H.
Abraham, Andrew T.
Okonoboh, Peters
author_facet Salabei, Joshua K.
Asnake, Zekarias T.
Ismail, Zeeshan H.
Charles, Kipson
Stanger, Gregory-Thomas
Abdullahi, Abdullahi H.
Abraham, Andrew T.
Okonoboh, Peters
author_sort Salabei, Joshua K.
collection PubMed
description As COVID-19 continues to cause an increasing number of deaths worldwide, it is important that providers stay abreast with new research related to the pathophysiology of COVID-19 disease presentation states and clinical management. It is now well recognized that COVID-19 affects extrapulmonary organs, particularly the cardiovascular system. For example, cardiogenic shock has been increasingly observed in patients with COVID-19, owing to the various mechanisms involved and the affinity of the SARS-CoV-2 virus to cells comprising the cardiovascular system. In this review, we have briefly discussed the link between the cardiovascular system and COVID-19 infection, focusing on underlying mechanisms including but not limited to cytokine storm, direct virus-induced myocarditis, and ST-elevation myocardial infarction leading to cardiogenic shock. We have highlighted the cardiovascular risk factors associated with disease prognostication in COVID-19 patients. We have also briefly discussed vasopressors and inotropes used for treating shock and presented their mechanism of action, contraindications, and side effects in the hopes of providing a quick reference to help the provider optimize management of COVID-19 patients presenting with cardiovascular complications such as shock.
format Online
Article
Text
id pubmed-8830924
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Southern Society for Clinical Investigation. Published by Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-88309242022-02-11 COVID-19 and the cardiovascular system: an update Salabei, Joshua K. Asnake, Zekarias T. Ismail, Zeeshan H. Charles, Kipson Stanger, Gregory-Thomas Abdullahi, Abdullahi H. Abraham, Andrew T. Okonoboh, Peters Am J Med Sci Review Article As COVID-19 continues to cause an increasing number of deaths worldwide, it is important that providers stay abreast with new research related to the pathophysiology of COVID-19 disease presentation states and clinical management. It is now well recognized that COVID-19 affects extrapulmonary organs, particularly the cardiovascular system. For example, cardiogenic shock has been increasingly observed in patients with COVID-19, owing to the various mechanisms involved and the affinity of the SARS-CoV-2 virus to cells comprising the cardiovascular system. In this review, we have briefly discussed the link between the cardiovascular system and COVID-19 infection, focusing on underlying mechanisms including but not limited to cytokine storm, direct virus-induced myocarditis, and ST-elevation myocardial infarction leading to cardiogenic shock. We have highlighted the cardiovascular risk factors associated with disease prognostication in COVID-19 patients. We have also briefly discussed vasopressors and inotropes used for treating shock and presented their mechanism of action, contraindications, and side effects in the hopes of providing a quick reference to help the provider optimize management of COVID-19 patients presenting with cardiovascular complications such as shock. Southern Society for Clinical Investigation. Published by Elsevier Inc. 2022-08 2022-02-11 /pmc/articles/PMC8830924/ /pubmed/35151635 http://dx.doi.org/10.1016/j.amjms.2022.01.022 Text en © 2022 Southern Society for Clinical Investigation. Published by Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Review Article
Salabei, Joshua K.
Asnake, Zekarias T.
Ismail, Zeeshan H.
Charles, Kipson
Stanger, Gregory-Thomas
Abdullahi, Abdullahi H.
Abraham, Andrew T.
Okonoboh, Peters
COVID-19 and the cardiovascular system: an update
title COVID-19 and the cardiovascular system: an update
title_full COVID-19 and the cardiovascular system: an update
title_fullStr COVID-19 and the cardiovascular system: an update
title_full_unstemmed COVID-19 and the cardiovascular system: an update
title_short COVID-19 and the cardiovascular system: an update
title_sort covid-19 and the cardiovascular system: an update
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8830924/
https://www.ncbi.nlm.nih.gov/pubmed/35151635
http://dx.doi.org/10.1016/j.amjms.2022.01.022
work_keys_str_mv AT salabeijoshuak covid19andthecardiovascularsystemanupdate
AT asnakezekariast covid19andthecardiovascularsystemanupdate
AT ismailzeeshanh covid19andthecardiovascularsystemanupdate
AT charleskipson covid19andthecardiovascularsystemanupdate
AT stangergregorythomas covid19andthecardiovascularsystemanupdate
AT abdullahiabdullahih covid19andthecardiovascularsystemanupdate
AT abrahamandrewt covid19andthecardiovascularsystemanupdate
AT okonobohpeters covid19andthecardiovascularsystemanupdate